MENU
MBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Moleculin Biotech (MBRX) Earnings Date & Reports
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
MBRX is expected to report earnings to rise 607.14% to -989 cents per share on November 12
Q3'26
Est.
$-9.90
Q2'26
Beat
by $0.25
Q4'25
Beat
by $8.15
Q3'25
Beat
by $0.57
Q2'25
Beat
by $0.76
The last earnings report on August 14 showed earnings per share of -139 cents, beating the estimate of -164 cents. With 45.13K shares outstanding, the current market capitalization sits at 128.63M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Industry
Pharmaceuticals Major
Address
5300 Memorial Drive
Phone
+1 713 300-5160
Employees
17
Web
https://www.moleculin.com